ストックスクリーナーアプリを入手
293.61
0.57%
-1.69
アフターアワーズ：
293.61
Bio Rad Laboratories Inc (BIO) 最新ニュース
Bio-Plex Pro Human Cytokine Assays from Bio-Radmultiplex panels for immune research - AD HOC NEWS
BIOBio-Rad Laboratories Inc Latest SEC Filings - Finviz
Bio Rad Laboratories (BIO) Following ddPCR Expansion Narrative Looks Fully Valued - Sahm
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Evaluating Growth Amidst Stable Price Movements - DirectorsTalk Interviews
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (LSX:862449) - TradingView
Bio-Rad Laboratories, Inc. Class B Actuals & Estimates (FWB:BUW) - TradingView
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 6.5% Rally? GF Value Says Undervalued - GuruFocus
Bio-Rad rises as life-science tools deal activity and activist interest appear to lift sentiment - Quiver Quantitative
Bio-Rad Laboratories, Inc. Class A Actuals & Estimates (NYSE:BIO) - TradingView
Bio-Rad Laboratories Jumps 5.6% Amid Sector-Wide Rally - AlphaStreet
BIO Forecast — Price Target — Prediction for 2027 - TradingView
Lyme Disease Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Abbott, Bio-Rad Labs, Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Barchart.com
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? - AOL.com
Bio Rad Laboratories Inc (BIOb) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
2x Valuation Gap: BIO vs. CRL — Who’s Wrong? - NAI500
Bio Rad Laboratories Inc (BIO) Institutional Confidence - TradingKey
Why Bio-Rad’s Bio-Plex Pro Human Cytokine Screening Panel still matters in the lab - AD HOC NEWS
Bio Rad Laboratories Inc (BIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bio Rad Laboratories Inc (BIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bio Rad Laboratories Inc (BIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio Rad Laboratories Inc (BIOb) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bio Rad Laboratories Inc (BIOb) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bio Rad Laboratories Inc (BIOb) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bio Rad Laboratories Inc (BIOb) Institutional Confidence - TradingKey
Bio Rad Laboratories Inc (BIOb) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bio Rad Laboratories Inc (BIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bio Rad Laboratories Inc (BIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bio Rad Laboratories Inc (BIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bio Rad Laboratories Inc (BIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bio Rad Laboratories Inc (BIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bio Rad Laboratories Inc (BIOb) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio Rad Laboratories Inc (BIOb) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bio Rad Laboratories Inc (BIOb) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
From Concept To Cure: Using AAV In Gene Therapy - Pharmaceutical Online
(BIO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
In Fight With GC, Bio-Rad Adds Quinn Emanuel to Legal Team - Law.com
Bio-Rad Receives MicroVal Validation for Two EZ-Check Listeria Testing Kits - Quality Assurance & Food Safety
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Limited Upside Amid a Competitive Landscape - DirectorsTalk Interviews
Bio-Rad receives MicroVal validation for EZ-Check™ Listeria testing kits - News-Medical
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports - MSN
Bio Rad Laboratories Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
In Vitro Diagnostic (IVD) Quality Control Market Overview, Key - openPR.com
(BIO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BioRad Listeria Test Kits Receive MicroVal Certification - Food Safety Magazine
Bio-Rad receives microVal validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network
Bio-Rad (BIO) Q1 2026 Earnings Transcript - AOL.com
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential - DirectorsTalk Interviews
IVD Quality Control Market Size, Share | Industry Report [2034] - Fortune Business Insights
Why Bio-Rad Laboratories, Inc. (NYSE:BIO) Could Be Worth Watching - 富途牛牛
Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ - Moomoo
A Look at Bio-Rad Laboratories Inc (BIO) After 4.2% Gain -- GF V - GuruFocus
[144] BIO-RAD LABORATORIES, INC. SEC Filing - Stock Titan
Bio-Rad Laboratories stock (US09062X1037): sector focus as Elliott stake and price gains keep NYSE l - AD HOC NEWS
Bio-Rad’s valuation may be hard to justify as revenue growth lags industry forecasts. Optimistic investor sentiment could reverse if growth fails to improve, potentially putting pressure on the stock. - Moomoo
Is Elliott’s Sartorius Push Altering The Investment Case For Bio-Rad Laboratories (BIO)? - Yahoo Finance
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Medical Device Terrain with a 3.22% Upside - DirectorsTalk Interviews
Is It Time To Reassess Bio-Rad Laboratories (BIO) After Its Recent 16% Weekly Surge? - Sahm
Bio-Rad Laboratories, Inc. Class B Trade Ideas — BOATS:BIO.B - TradingView
5.64%
大文字化:
|
ボリューム (24 時間):